DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-Term T-Cell Responses in Patients With Recurrent Prostate Cancer

Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/cji.0b013e3181dda23e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Prostatic Acid Phosphatase (ACPP; PAP)

Science-Business eXchange
2008English

Poxviral-Based Vaccine Elicits Immunologic Responses in Prostate Cancer Patients

OncoImmunology
OncologyAllergyImmunology
2014English

APC8015, a Therapeutic Vaccine for Prostate Cancer, Targets Prostatic Acid Phosphatase

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2005English

Radioimmunoassay of Serum Prostatic Acid Phosphatase in Prostatic Cancer.

BMJ
1978English

Prostate Cancer Derived Prostatic Acid Phosphatase Promotes an Osteoblastic Response in the Bone Microenvironment

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2013English

P19-44. Priming With a DNA Vaccine Enconding HIV CD4+ T Cell Epitopes Enhances Responses Against Subsequent Immunization With Plasmid Encoding Vif

Retrovirology
VirologyInfectious Diseases
2009English

Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected With SARS Coronavirus

PLoS ONE
Multidisciplinary
2006English

Characterization of T-Cell Responses in Macaques Immunized With a Single Dose of HIV DNA Vaccine

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

Cell-Free DNA: A Novel Biomarker for Patients With Prostate Cancer?

The Open Prostate Cancer Journal
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy